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BACKGROUND. Cell lines can provide powerful model systems for the study of human
tumorigenesis. However, the human prostate cancer cell lines studied most intensively by
investigators (PC3, DU145, and LNCaP) were established from metastatic lesions, and it is
unlikely that they accurately recapitulate the genetic composition or biological behavior of
primary prostate tumors. Cell lines more appropriate for the study of human prostate primary
tumors would be those derived from spontaneously immortalized cells; unfortunately, ex-
planted prostate cells survive only short-term in culture, and rarely immortalize spontane-
ously. Therefore, we examined whether cell lines developed through viral gene-mediated
immortalization of human normal or primary tumor prostate epithelium express aspects of
the normal or malignant phenotypes, and could serve as appropriate models for normal or
transformed human prostatic epithelium.
METHODS. To accomplish these goals, we assessed the phenotypic expression of cell cul-
tures established through the immortalization of normal (1532N, 1535N, 1542N, and PrEC-T)
or malignant (1532T, 1535T, and 1542T) human prostate epithelium with the E6 and E7 genes
of HPV-16, or the large T antigen gene of SV40.
RESULTS. Examination of these cell lines for their proliferative rates and their abilities to
grow with or without serum or androgen stimulation, to form colonies in soft agar, or to form
tumors in vivo, suggests that they may serve as valid, useful tools for the elucidation of
prostate tumorigenesis. Moreover, the observation of structural alterations involving chro-
mosome 8, including gain of 8q in 3 of the 4 cell lines expressing aspects of the malignant
phenotype, implies that these cell lines accurately recapitulate the genetic composition of
primary prostate tumors.
Grant sponsor: National Institutes of Health; Grant numbers: R29
CA60948, 1P50 CA69568 SPORE in Prostate Cancer; Grant sponsor:
American Cancer Society; Grant number: RPG-98-338-01-MGO.
*Correspondence to: Jill A. Macoska, Ph.D., Section of Urology, De-
partment of Surgery, University of Michigan, 7306 CCGC, 1500 East
Medical Center Drive, Ann Arbor, MI 48109-0946.
E-mail: jcoska@umich.edu
Received 1 November 1999; Accepted 16 March 2000
The Prostate 44:164–171 (2000)
© 2000 Wiley-Liss, Inc.
CONCLUSIONS. Taken together, these data suggest that cell lines generated from immor-
talized normal or primary tumor epithelium may be useful for the elucidation of early trans-
forming events in the prostate. Prostate 44:164–171, 2000. © 2000 Wiley-Liss, Inc.
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INTRODUCTION
Prostate cancer is a major health concern world-
wide. There will be approximately 180,400 new cases
of prostate cancer diagnosed in 2000, making it the
most commonly diagnosed cancer in the United States
[1]. Unfortunately, very little is known about the pro-
cess of prostate cancer initiation and progression to
the malignant phenotype. The uncertain time course
and heterogeneity of the disease hinder elucidation of
prostate tumorigenesis, and make the procurement of
clinical specimens for study from appropriate time
points during prostate tumor progression largely im-
possible.
Therefore, we and others have developed prostate
cancer cell lines as model systems to examine the pro-
cess of malignant transformation. In particular, the es-
tablishment of long-term cell cultures through the im-
mortalization of normal and primary tumor-derived
epithelium from radical prostatectomy specimens
with the E6 and E7 genes of the human papilloma
virus 16 (HPV-16), or the large T gene of the simian
virus 40 (SV40), have provided valuable tools toward
the analysis of tumor development in the prostate [2].
In this study, we report on the expression of the
malignant phenotype in primary tumor-derived hu-
man prostate cell cultures. Our observations suggest
that prostate epithelium immortalized through trans-
fection with the HPV-16 E6 and E7 or SV40 large T
genes may serve as valid, useful tools for the elucida-
tion of malignant transformation in the prostate.
MATERIALS AND METHODS
Cell Culture
The HT-29 human colon cell line was grown in
minimum essential medium (MEM) (Gibco BRL, Gai-
thersburg, MD) supplemented with 10% fetal bovine
serum (FBS) (BioWhittaker, Walkersville, MD) and 1%
penicillin/streptomycin/fungizone antibiotic mixture
(BioWhittaker). All other cell lines were grown in de-
fined keratinocyte-SFM (Gibco BRL), 5% FBS, and 1%
penicillin/streptomycin/fungizone antibiotic mixture
(BioWhittaker). All cell lines were grown at 37°C in a
humidified incubator with 5% CO2.
Immortalization
The 1532N, 1535N, 1542N, 1532T, 1535T, and 1542T
cell lines were produced through immortalization of
primary human prostate epithelial cells obtained from
radical prostatectomy by transduction with a recom-
binant retrovirus encoding the E6 and E7 genes of
HPV-16, as previously described [2]. The PrEC-T cells
were produced through immortalization of normal
prostate epithelial cells (Clonetics, Inc., Walkersville,
MD) by transfection with the pMT10D plasmid (Japa-
nese Cancer Research Resources Bank, Tokyo, Japan)
containing sequences encoding the simian virus 40
(SV40) large T antigen.
Growth Curves
Cells were detached using 0.05% trypsin and plated
in triplicate at a density of 10,000 cells/well in sterile
six-well tissue culture plates (Fisher Scientific, Hano-
ver Park, IL). PrEC-T cells were plated at a density of
5,000 cells/well. Each cell line was grown in media
either with or without serum supplemented with 0.1%
bovine serum albumin (BSA) (Sigma Chemical Co., St.
Louis, MO) for a period of 2 weeks, with media
changes every 2–3 days. Plates were incubated at 37°C
in 5% CO2. Twenty-four hours later (time point 0 hr),
media were aspirated and wells were washed with 5
ml of sterile 1 × phosphate-buffered saline (PBS). PBS
was aspirated, and 2 ml of hypotonic solution (0.01 M
HEPES and 0.0015 M MgCl2) were added to each well.
Plates were incubated for 10–15 min at room tempera-
ture on a rocking platform. Two hundred microliters
of lysis buffer (0.13 M c-ethylhexadecyldimethylam-
monium bromide and 3% acetic acid) were added to
each well. Plates were incubated for 10 min at room
temperature on a rocking platform. Ten milliliters of
isoton II diluent solution (Coulter Corp., Miami, FL)
were added to each well and gently mixed. Nuclei
were counted using a Coulter Counter (Coulter
Corp.). Averages and standard deviations of cell num-
ber were calculated for each time point.
Colony Formation Assays
Five hundred microliters of media and 500 ml of 1%
agar at 50°C were mixed in sterile 15-ml conical tubes
(Fisher Scientific) and quickly poured into each well of
six-well sterile tissue culture plates. The plates were
allowed to solidify for several hours. Cells were added
to 500 ml of warm media at densities of 105, 104, or 103,
followed by the addition of 200 ml of sterile warm
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water and 300 ml sterile 1% agar (50°C). Tubes were
quickly mixed and poured onto the solidified layer of
the six-well plates and allowed to solidify for several
hours. Each plate was fed with 1 ml of the appropriate
media and placed at 37°C in a humidified incubator
containing 5% CO2. Each well was fed with 1 ml of
media every 3 days. After 3 weeks, cells were stained
by overnight incubation with 10 mg/ml tetrazolium
violet (Sigma Chemical Co.) in the media at 37°C with
CO2. Each well was viewed and colonies were
counted. HT-29 cells were used as positive controls for
colony formation.
Tumor Formation in Athymic Mice
To determine tumorigenicity in vivo for the 1532T,
1535T, and 1542T cell lines, 1 × 107 cells in 0.2 ml of
phosphate-buffered saline (PBS) were injected subcu-
taneously into the mid-dorsal interscapular region of
adult athymic mice. The mice were observed for 5
months for tumor development.
Androgen Sensitivity Assays
Ten thousand cells of the 1535N, 1535T, 1532T, or
1542T lines were plated into sterile six-well plates. Me-
dia containing no serum was supplemented with 0.1%
BSA with no R1881 (methyltrienolone) (New England
Nuclear Life Sciences, Boston, MA) as controls or con-
centrations of 10−7, 10−8, or 10−9 MR1881. Plates were
placed into 37°C humidified incubators with 5% CO2
for 1 week with changes of media every 2 days. Cells
were lysed and nuclei were counted as described
above.
Immunohistochemistry
Cells were detached using trypsin and plated into
sterile chamber slides (Fisher Scientific). Media were
aspirated and the wells were washed with 1 × PBS.
Cells were fixed using a 50% methanol/50% acetic
acid solution for 15 min at 4°C. Wells were washed
with 1 × PBS, and cells were stained using a pan cy-
tokeratin antibody mixture containing clones C-11,
PRK-26, CY-90, KS-1A3, M20, and A53-B/A2 or an
isotype control antibody (Sigma Chemical Co.), using
the UniTect™ immunohistochemistry detection sys-
tem (Oncogene Science, Inc., Cambridge, MA), follow-
ing the manufacturer’s protocol. Slides were viewed
using light microscopy.
RESULTS
Expression of the malignant phenotype was as-
sessed for all cell lines by evaluating their proliferative
rates (doubling times), their ability to grow in low
serum and form colonies in soft agar and in vivo in
athymic mice, and their sensitivity to androgen.
Growth Curves
Differences in cell doubling times for cells grown in
the presence or absence of fetal bovine serum (FBS)
were examined. The 1532T, 1535T, and the 1542T hu-
man malignant prostate cell lines had faster doubling
times than the 1532N, 1535N, and 1542N human nor-
mal prostate cell lines. Specifically, the doubling times
for the malignant cell lines were in the range of 24–31
hr, whereas the range of the normal cell lines was from




















1532N Normal prostate 32 hr None Yes No ND 2 copies of intact 8p/nd/
1535N Normal prostate 41 hr None Yes No ND 2 copies of intact 8p/nd/
1542N Normal prostate 48 hr None Yes No ND 2 copies of intact 8p/nd/
PREC-T Normal prostate 36 hr 76 (6) Yes ND ND nd/gain of 8q
1532T Malignant prostate 24 hr 308 (17) Yes No No One copy of 8p deleted/[iso(8q)]
1535T Malignant prostate 27 hr 168 (11) Yes No No 2 copies of intact 8p/nonclonal
deletion of one copy of 8p
1542T Malignant prostate 31 hr 132 (17) Yes No No One copy of 8p deleted/
structural alterations of
chromosome 8
HT-29c Malignant colon 25 hr 2,240 (339) ND ND Yesb 1 copy of 8p deleted/[iso(8q)])
aAs reported here and in Bright et al. [2] and Macoska et al. [7].
bAs reported in Gustafson et al. [31].
cIncluded as a control; not derived from prostate tissue.
ND = not determined.
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32–48 hr (Table I). The PrEC-T cell line, which was
established from normal prostatic epithelium after
stable transfection with the SV40 large T antigen gene,
had a doubling time of 36 hr, which was intermediate
to those of the normal and tumor-derived prostate cell
lines. No significant differences in growth rates were
observed for any of the cell lines when grown in the
presence or absence of FBS (Fig. 1). Hence, the tumor
lines, as well as the normal lines, were able to grow in
low serum.
Colony Formation
The ability of cells to form colonies in soft agar
denotes that they have lost contact inhibition, a trait of
the malignant or transformed phenotype. In order to
determine whether cells demonstrated this trait, they
were embedded in 0.5% agar and allowed to grow for
3 weeks, using HT-29 cells as a positive control for
colony formation. The only cell lines that were able to
form colonies in this assay were the HT-29, 1532T,
1535T, 1542T, and PrEC-T cell lines. The ability of
prostate cell lines to form colonies in soft agar was
1532T > 1535T > 1542T > PrEC-T. The 1532N, 1535N,
and 1542N cell lines were unable to produce any colo-
nies in this assay (Table I).
Tumor Formation in Athymic Mice
Subcutaneous inoculation of 1 × 107 cultured cells
into athymic mice failed to produce measurable tu-
mors from the 1532T, 1535T, or 1542T cell lines after 5
months of observation.
Androgen Sensitivity Assays
In order to see if the cell lines were sensitive to
androgen, the 1535N, 1532T, 1535T, and 1542T cells
were grown in serum-free media at 0, 10−7, 10−8, and
10−7 M R1881. Less than a twofold difference in
growth was observed for cells exposed to androgen
compared to the controls in any of the cell lines tested
(Fig. 2).
Immunohistochemistry
In order to see if the cell lines were entirely epithe-
lial in origin and without fibroblastic or neuroendo-
Fig. 1. Effect of fetal bovine serum (FBS) on cell growth. Cell number (y-axis, logarithmic scale) at consecutive time points over a 2-week
period (x-axis, linear scale) is shown for normal-derived cells grown in the presence (solid squares) or absence (solid circles) of FBS, and
for tumor-derived cells grown in the presence (solid triangles) or absence (solid diamonds) of FBS. Upper left, 1535 cells; upper right,
1532 cells; lower left, 1542 cells; lower right, PrEC-T cells.
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crine contamination, cells were stained using a cyto-
keratin antibody mixture containing anti-cytokeratin
antibodies and compared to cells stained with an iso-
type control (Table I). All of the cells examined stained
uniformly and completely for cytokeratins, demon-
strating that the cell lines were entirely epithelial and
without fibroblast contamination (Fig. 3).
DISCUSSION
Cell lines can provide powerful model systems for
studying the acquisition and expression of the malig-
nant phenotype for the tissues from which they were
derived. This is especially true when correlations be-
tween gross genotypic changes and expression of the
malignant phenotype are attempted, as such studies
using mouse models are often confounded by prob-
lems associated with mouse-human synteny. Even so,
the human prostate cancer cell lines studied most in-
tensively by prostate cancer investigators (PC3,
DU145, LNCaP, and TSU-Pr1) were all established
from metastatic lesions [3–6]. As such, it is unlikely
that these cell lines accurately recapitulate the genetic
composition or biological behavior of primary pros-
tate tumors. Cell lines more appropriate for the study
of human prostate primary tumors would be those
derived from spontaneously immortalized cells; un-
fortunately, explanted prostate cells survive only
short-term in culture, and rarely immortalize sponta-
neously. The use of viral transforming proteins to im-
mortalize normal and primary tumor-derived human
prostatic epithelium has allowed the continual propa-
gation of these cells in vitro [2]. The cell lines exam-
ined in the present study were created through the
transduction, and subsequent immortalization, of nor-
mal and malignant prostatic tissues with the E6 and
E7 transforming genes of HPV-16 or with the large T
antigen gene of SV40 [2,7].
The experiments reported here were designed to
assess the extent to which cell lines developed through
immortalization of normal or primary tumor-derived
prostatic epithelium with viral genes would express
aspects of the normal or malignant phenotypes. This
information would indicate whether such cell lines
successfully recapitulated the biological behavior of
the normal or malignant prostatic epithelium from
which they were derived, and hence, whether they
could serve as useful model systems for prostate biol-
ogy and malignant transformation.
We first examined the growth of HPV-16 E6/E7
immortalized cell lines in the presence or absence of
growth factors. All prostate cell lines examined
(1532N, 1535N, 1542N, 1532T, 1535T, and 1542T) were
able to grow in the absence of serum, with or without
androgen supplementation, at rates comparable to
Fig. 2. Androgen sensitivity assay. Sensitivity to androgen was
assessed for 1535N, 1532T, 1535T, and 1542T cells after growth
in serum-free media at 0, 10−7, 10−7, and 10−7M R1881. Less than
a twofold difference in growth was observed for cells exposed to
a synthetic androgen, methyltrienolone (R1881), compared to the
controls in any of the cell lines tested.
Fig. 3. Cytokeratin expression. Cells were stained using a panel
of anti-cytokeratin antibodies. Photomicrographs of the stained
slides taken at 10× and 40× (insets) magnification are shown for
cells stained with anti-cytokeratins in (A) 1535N cells, (C) 1535T
cells, (D) 1542T cells, and (E) 1532T cells, or (B) the isotype
control in 1535N cells.
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those achieved with serum added to the media. We
then examined the doubling times of the HPV-16 E6/
E7 immortalized cells under normal growing condi-
tions (with serum). Interestingly, doubling times for
the malignant cell lines were 24–31 hr, considerably
shorter than those of the normal cell lines at 32–48 hr.
Thus, the first observed phenotypic difference be-
tween HPV-16 E6/E7 immortalized cells was shorter
doubling times for primary tumor- compared to nor-
mal-derived prostatic epithelial cell lines. The second
phenotypic difference observed for the HPV-16 E6/E7
immortalized cells was that all three primary tumor-
derived cell lines, but none of the corresponding nor-
mal-derived cell lines, were able to form colonies in
soft agar. Thus, the primary tumor-derived cell lines
were clearly distinguishable from the normal-derived
cell lines by both a rapid doubling rate and the dem-
onstration of anchorage independence. Not surpris-
ingly, an inverse relationship was observed between
doubling time and ability to form colonies in soft agar.
Of the primary tumor-derived cell lines, the one with
the shortest doubling time, 1532T, was also the one
with the greatest ability to form colonies in soft agar
(308 ± 17). In contrast, the primary tumor-derived cell
line with the longest doubling time, 1542T, was least
able to form colonies in soft agar (168 ± 11). Thus, if
doubling time and anchorage independence can be
used as criteria to measure expression of the malig-
nant phenotype, then these cell lines may be ranked by
their abilities to do so as 1532T > 1535T > 1542T.
The PrEC-T cell lines demonstrated a phenotype
with aspects common to both the HPV-16 E6/E7 im-
mortalized normal- and primary tumor-derived cells.
Like the HPV-16 E6/E7-immortalized cells, PrEC-T
cells were able to grow in low serum and did not
respond to androgen stimulation. However, the dou-
bling time for PrEC-T cells was 36 hr, which was in-
termediate to those of the normal- and primary tumor-
derived prostate cell lines. Also, PrEC-T cells were the
only normal-derived cells to demonstrate any ability
to form colonies in soft agar, though this ability was
limited (76 ± 6). Thus, it appears that transfection with
large T antigen resulted in both the immortalization
and early transformation of PrEC-T cells.
These observations are consistent with other stud-
ies suggesting that the mechanism by which expres-
sion of the HPV-16 E6 and E7 genes results in cellular
immortalization is through inactivation of the p53 pro-
tein by viral E6, destabilization of the Rb protein by
viral E7, and activation of telomerase [8–11]. The com-
bined effect of these activities is to bypass cell cycle
checkpoints, reestablish telomere lengthening, and
overcome replicative senescence, i.e., become immor-
talized. None of these events, however, are sufficient
for cellular transformation or expression of the malig-
nant phenotype [12]. In contrast, the SV40 large T an-
tigen, which also abrogates the p53 and Rb pathways,
can mediate both cellular immortalization and trans-
formation [13–15]. Cells transformed by SV40 typi-
cally express some aspects of the malignant pheno-
type, including reduced dependency on growth factor
(e.g., serum) requirements and anchorage indepen-
dence [16]. It has been proposed that the ability of
SV40 large T antigen to induce transformation may be
due to mutations in other cellular genes not directly
effected by T antigen [17]. Therefore, the ability of the
SV40 large T-transfected, but not HPV-16 E6/E7-
transfected, normal prostate cells to express aspects of
the malignant phenotype consistent with initial trans-
formation may be due to differences in the genetic
background of these cells. These differences are likely
due to genetic alterations acquired due to, or conse-
quent to, expression of viral proteins and the immor-
talization process. For example, many cytogenetic
changes have been described for cells immortalized
through transfection with HPV or SV40 [11,18–21].
None of the HPV-16 immortalized human prostate
primary tumor-derived cell lines examined here were
able to form detectable tumors in vivo in athymic
mice. These findings are similar to those reported for
CA-HP-10 cells, an HPV-18 immortalized human
prostate adenocarcinoma-derived cell line, which
were able to form only small nodules of nonprolifer-
ating cells in athymic mice [22]. Bright et al. also re-
ported that subcutaneous injection of HPV-16 E6/E7
immortalized primary tumor-derived prostate cancer
cell lines 1510-CPTx, 1512-CPTx, or 1519-CPTx failed
to produce tumors in vivo in athymic mice [2]. Taken
together, these studies suggest that cell lines devel-
oped from human prostate primary tumors are unable
to express the full spectrum of the malignant pheno-
type. Rather, these cells express phenotypic traits
perhaps more consonant with the primary, localized
tumors from which they were derived (faster prolif-
eration rate, reduced dependence on growth factors,
and anchorage independence) and are unable to ex-
press phenotypic traits associated with more aggres-
sive, metastatic tumors (e.g., the ability to form tumors
in vivo). It is perhaps not surprising that human pros-
tate cell lines capable of forming tumors in vivo were
all derived from metastatic lesions and possess very
aberrant genotypes [3–6,23]. It is possible, then, that
genetic alterations in addition to those demonstrated
by the cell lines examined here (see below) may be
required for full expression of the malignant pheno-
type.
Of the genetic changes observed in the cell lines
utilized in this study, it is interesting to note that 4 of
the 5 cells lines expressing aspects of the malignant
phenotype (1532T, 1542T, PreC-T, and HT-29) demon-
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strated structural alterations of chromosome 8 [2,7,18].
The 1532T and HT-29 cell lines are characterized by
i(8q) chromosome formation; the 1542T karyotype in-
cludes i(8q), der(8;20)(q10;p10), and der(8;21)(p10;q10)
chromosomes; and PrEC-T demonstrates gain of the
8q chromosomal region [7]. Therefore, gain of all or
part of 8q was observed in three prostate-derived cell
lines (1532T, 1542T, and PrEC-T), and was accompa-
nied by the loss of 8p sequences in 2 of the 3 cell lines
(1532T and 1542T). Deletion of one or both copies of 8p
is a very frequent and likely early event in prostate
tumorigenesis [24–26]. Moreover, other studies have
reported 8q gain in advanced prostatic cancer [27–30].
Therefore, it is certainly possible that loss of 8p se-
quences and/or gain of 8q sequences contributed to
the ability of these cells (especially PrEC-T) to express
aspects of the malignant phenotype. If so, these cell
lines, and others like them, generated from normal or
primary tumor epithelium, may offer unique models
for prostate tumorigenesis, and may help elucidate
early transforming events in the prostate.
ACKNOWLEDGMENTS
The authors thank Dr. Suzanne Topalian for her
kind gift of the HPV-immortalized cell lines.
REFERENCES
1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics
2000. CA Cancer J Clin 2000;50:7–33.
2. Bright K, Vocke CD, Emmert-Buck MR, Duray PH, Solomon D,
Fetsch P, Rhim JS, Linehan WM, Topalian SL. Generation and
genetic characterization of immortal human prostate epithelial
cell lines derived from primary cancer specimens. Cancer Res
1997;57:995–1002.
3. Kaign ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW. Es-
tablishment and characterization of a human prostatic carci-
noma cell line (PC-3). J Urol 1979;17:16–23.
4. Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF.
Isolation of a human prostate carcinoma cell line (DU145). Int J
Cancer 1978;21:274–281.
5. Horoszewicz AS, Leong SS, Kawinski E, Karr JP, Rosenthal H,
Chu TM, Mirand EA, Murphy GP. LNCaP model of human
prostatic carcinoma. Cancer Res 1983;43:1809–1818.
6. Hzumi T, Yazaki T, Kanoh S, Kondo I, Koiso K. Establishment
of a new prostatic carcinoma cell line (TSU-PR1). J Urol 1987;
137:1304–1306.
7. Macoska JA, Beheshti B, Rhim JS, Hukku B, Lehr J, Pienta KJ,
Squire JA. Genetic characterization of immortalized prostate ep-
ithelial cell cultures: evidence for structural rearrangements of
chromosome 8 and i(8q) chromosome formation in primary tu-
mor-derived cells. Cancer Genet Cytogenet 2000; in press.
8. Huibregtse JM, Beaudenon SL. Mechanism of HPV E6 proteins
in cellular transformation. Semin Cancer Biol 1996;7:317–326.
9. Jones DL, Thompson DA, Munger K. Destabilization of the RB
tumor suppressor protein and stabilization of p53 contribute to
HPV type 16 E7-induced apoptosis. Virology 1997;239:97–107.
10. Steeenbergen RDM, Walboomers JMM, Meijer CJLM, van der
Raaij-Helmer EMH, Parker JN, Chow LT, Broker TR, Snijders
PJF. Transition of human papillomavirus type 16 and 18 trans-
fected human foreskin keratinocytes towards immortality: acti-
vation of telomerase and allele losses at 3p, 10p, 11q and/or 18q.
Oncogene 1996;13:1249–1257.
11. Coursen JD, Bennett WP, Gollahon L, Shay JW, Harris CC. Ge-
nomic instability and telomerase activity in human bronchial
epithelial cells during immortalization by human papillomavi-
rus-16 E6 and E7 genes. Exp Cell Res 1997;235:245–253.
12. Morales CP, Holt SE, Ouellette M, Kaur KJ, Yan Y, Wilson KS,
White MA, Wright WE, Shay JW. Absence of cancer-associated
changes in human fibroblasts immortalized with telomerase.
Nat Genet 1999;21:115–118.
13. Brugge JS, Butel JS. Role of the simian virus 40 gene A function
in maintenance of transformation. J Virol 1975;15:619–635.
14. Martin RG, Chou JY. Simian virus 40 functions required for the
establishment and maintenance of malignant transformation. J
Virol 1975;15:599–612.
15. Tegtmeyer P. Function of simian virus 40 gene A in transform-
ing infection. J Virol 1975;15:613–618.
16. Jha KK, Banga S, Palejwala V, Ozer HL. SV40-mediated immor-
talization. Exp Cell Res 1998;245:1–7.
17. Ozer HL, Banga SS, Dasbupta T, Houghton JM, Hubbard K, Jha
KK, Kim S-H, Lehahan M, Pang Z, Pardinas JR, Patsalis P. SV40-
mediated immortalization of human fibroblasts. Exp Gerontol
1996;31:303–310.
18. Gilles C, Piette J, Rombouts S, Laurent C, Foidart J-M. Immor-
talization of human cervical keratinocytes by human papilloma-
virus type 33. Int J Cancer 1993;53:872–879.
19. Oda D, Bigler L, Mao E-J, Disteche CM. Chromosomal abnor-
malities in HPV-16 immortalized oral epithelial cells. Carcino-
genesis 1996;17:2003–2008.
20. Hoffschir F, Ricoul M, Dutrillaux B. SV40-transformed human
fibroblasts exhibit a characteristic chromosomal pattern. Cyto-
genet Cell Genet 1988;49:264–268.
21. Ray FA, Peabody DS, Cooper J, Scott-Cram L, Kraemer PM.
SV40 T antigen alone drives karyotype instability that precedes
neoplastic transformation of human diploid fibroblasts. J Cell
Biochem 1990;42:13–31.
22. Weijerman PC, Konig JJ, Wong ST, Niesters HG, Peehl DM.
Lipofection mediated immortalization of human prostatic epi-
thelial cells of normal and malignant origin using human pap-
illomavirus type 18 DNA. Cancer Res 1994;54:5579–5583.
23. Beheshti B, Karaskova J, Park OC, Squire J, Beatty BG. Identifi-
cation of a high frequency of chromosomal rearrangements in
the centromeric regions of prostate cancer cell lines by sequen-
tial Giemsa-banding and spectral karyotyping. Mol Diagn 2000;
5:23–32.
24. Macoska JA, Trybus TM, Benson PD, Sakr WA, Grignon DJ,
Wojno KD, Pietruk T, Powell IJ. Evidence for three tumor su-
pressor gene loci on chromosome 8p in human prostate cancer.
Cancer Res 1995;55:5390–5395.
25. Vocke C, Pozzatti RO, Bostwick DG, Florence CD, Jennings SB,
Strup SE, Duray PH, Liotta LA, Emmert-Buck MR, Linehan
WM. Analysis of 99 microdissected prostate carcinomas reveals
a high frequency of allelic loss on chromosome 8p12–21. Cancer
Res 1996;56:2411–2416.
26. Prasad MA, Wojno KJ, Macoska JA. Homozygous and frequent
deletion of proximal 8p sequences in human prostate cancers:
identification of a potential tumor suppressor gene site. Genes
Chromosomes Cancer 1998;23:255–262.
27. Macoska J, Trybus TM, Sakr WA, Wolf MC, Benson PD, Powell
170 Schwab et al.
IJ, Pontes JE. Fluorescence in situ hybridization (FISH) analysis
of 8p allelic loss and chromosome 8 instability in human pros-
tate cancer. Cancer Res 1994;54:3824–3830.
28. Van Den Berg C, Guan X-Y, Von Hoff D, Jenkins R, Bittner M,
Griffin C, Kallioniemi O, Visakorpi T, McGill J, Herath J, Epstein
J, Sarosdy M, Meltzer P, Trent J. DNA sequence amplification in
human prostate cancer identified by chromosome microdissec-
tion: potential prognostic implications. Clin Cancer Res 1995;1:
11–18.
29. Takahashi S, Alcaraz A, Brown JA, Borell TJ, Herath JF, Berg-
stralh EJ, Lieber MM, Jenkins RB. Aneusomies of chromosomes
8 and Y detected by fluorescence in situ hybridization are prog-
nostic markers for pathological stage C (pT3N0M0) prostate car-
cinoma. Clin Cancer Res 1996;2:137–145.
30. Jenkins RB, Qian J, Lieber MM, Bostwick DG. Detection of c-
myc oncogene amplification and chromosomal aneusomies in
metastatic prostatic carcinoma by fluorescence in situ hybrid-
ization. Cancer Res 1997;57:524–531.
31. Gustafson CE, Wilson PJ, Lukeis R, Baker E, Woollatt E, Annab
L, Hawke L, Barrett JC, Chenevix-Trench G. Functional evi-
dence for a colorectal cancer tumor supperssor gene at chromo-
some 8p22–23 by monochrome transfer. Cancer Res 1996;56:
5238–5245.
Phenotypic Expression of Prostate Cell Cultures 171
